ÓÉÉϺ£ÊÐÏÖ´úÉúÎïÓëÒ½Ò©¹¤Òµ°ì¹«ÊÒÖ÷Àí£¬£¬£¬£¬ £¬ £¬£¬Ñï×Ó½­Ò©Òµ¼¯ÍÅ¡¢ÉϺ£ÊÐÉúÎïÒ½Ò©¿Æ¼¼¹¤ÒµÔö½øÖÐÐÄ¡¢ÉϺ£ÊпƼ¼»áÕ¹ÓÐÏÞ¹«Ë¾³Ð°ìµÄ¡°µÚÊ®Èý½ìÉϺ£¹ú¼ÊÉúÎïÊÖÒÕÓëÒ½Ò©×êÑлáôßÑï×Ó½­Ò©Òµ¼¯ÍÅÉúÎïÖÆ¼Á×êÑлᡱÓÚ6ÔÂ1ÈÕÔÚÉϺ£ÊÐÊÀ²©ÖÐÐľÙÐС£¡£¡£¡£¡£
    ÉϺ£ÊпƼ¼µ³Î¯Êé¼Ç³Â¿Ëºê¡¢ÉϺ£ÊÐʳÎïÒ©Æ·¼àÊÓÖÎÀí¾Ö¸±¾Ö³¤ÌÆÃñð©Ó¦Ñû³öϯÁË´ó»á²¢ÖºشÇ¡£¡£¡£¡£¡£Ñï×Ó½­Ò©Òµ¼¯ÍŶ­Ê³¤¡¢×Ü˾ÀíÐì¾µÈËÔÚÖ´ÇÖÐÌåÏÖ£¬£¬£¬£¬ £¬ £¬£¬ÔÚʵÑéÖÐÒ©¡¢»¯Ñ§Ò©¡¢ÉúÎïÒ©¡°ÈýÒ©¡±²¢¾ÙµÄÑз¢Õ½ÂÔÖУ¬£¬£¬£¬ £¬ £¬£¬ÒÔºóÑï×Ó½­Ò©Òµ½«°ÑÑз¢µÄÖØµãºÍÖØÐÄÏòÉúÎïÒ©×ªÒÆ£¬£¬£¬£¬ £¬ £¬£¬Ï£Íûͨ¹ýÕâ´Î×êÑлᣬ£¬£¬£¬ £¬ £¬£¬½øÒ»²½ÍØÕ¹ÊÓÒ°£¬£¬£¬£¬ £¬ £¬£¬Ãé×¼¹ú¼ÊÇ°ÑØ£¬£¬£¬£¬ £¬ £¬£¬ÏàʶÉúÎïÒ©×îÐÂÏ£ÍûºÍÉú³¤Ç÷ÊÆ£¬£¬£¬£¬ £¬ £¬£¬Í¬Ê±ÃæÏòÈ«ÇòÀ¿²Å£¬£¬£¬£¬ £¬ £¬£¬×·ÇóÏàÖúʱ»ú£¬£¬£¬£¬ £¬ £¬£¬½«ÉúÎïÒ©×ö´ó×öÇ¿£¬£¬£¬£¬ £¬ £¬£¬°ÑÑï×Ó½­Ò©Òµ´òÔì³É¾ßÓйú¼Ê¾ºÕùÁ¦µÄÒ»Á÷ÖÆÒ©ÆóÒµ¡£¡£¡£¡£¡£
    ÖпÆÔºÕÔ¹úÆÁԺʿ¡¢Ó¢¹ú¹ú¼ÒҽѧÑо¿Ôº¿Æ¼¼²¿×ܲÃDave Tapolczay¡¢ÃÀ¹úÄϼÓÖÝÉúÎïЭ»á×ܲÃJoseph PanettaµÈÁùλÀ´×Ôº£ÄÚÍâµÄÉúÎïÒ½Ò©ÁìÓòµÄר¼Ò¾ÍÉúÎïÖÆÒ©Éú³¤Ç÷ÊÆÓëÐÂÒ©Ñз¢ÏȺó×öÁËѧÊõÑݽ²£¬£¬£¬£¬ £¬ £¬£¬²¢Óë»áÕß¾ÙÐÐÁËÆÕ±éµÄ½»Á÷ºÍÌÖÂÛ¡£¡£¡£¡£¡£×¨¼ÒÃÇ»¹¾ÍÑï×Ó½­Ò©Òµ¼¯ÍÅÉúÎïÖÆ¼ÁµÄÑз¢¾ÙÐÐÁËרÌâ×êÑС£¡£¡£¡£¡£»£»£»£»£»£»£»£»áÉÏ£¬£¬£¬£¬ £¬ £¬£¬¶ÔÂѰ×Ò©Îï¡¢¶àëÄÒ©ÎС·Ö×ÓDNA¡¢ÊÜÌå°ÐÏò¶àëÄÒ©ÎïµÈ9¸öÏàÖúÑз¢ÏîÄ¿¾ÙÐÐÁË̽ÌÖ¡£¡£¡£¡£¡£
    ½ñÄêÊÇÑï×Ó½­Ò©Òµ¼¯Íލ³§40ÖÜÄê¡£¡£¡£¡£¡£Ñï×Ó½­Ò©Òµ¼¯Íųм̡°ÇóË÷½øÈ¡¡¢»¤ÓÓÖÚÉú¡±µÄÆóÒµÀíÄ£¬£¬£¬ £¬ £¬£¬¸ß¾Ù¡°Á¢ÒìΪÃñ¡¢¸ßÖÊ»ÝÃñ¡±µÄ´óÆì£¬£¬£¬£¬ £¬ £¬£¬ÖÂÁ¦ÓÚÖгÉÒ©¡¢»¯Ñ§Ò©¡¢ÉúÎïÒ©µÄÁ¢ÒìÑз¢£¬£¬£¬£¬ £¬ £¬£¬×ۺϾ­¼ÃÐ§ÒæÒÑÒ»Á¬10¶àÄêõÒÉíÌìÏÂҽҩǰÎåÇ¿¡£¡£¡£¡£¡£½üÄêÀ´£¬£¬£¬£¬ £¬ £¬£¬Ñï×Ó½­Ò©Òµ¼¯ÍżӴóÁË×ÔÖ÷֪ʶ²úȨÐÂÒ©µÄÑз¢£¬£¬£¬£¬ £¬ £¬£¬30¶àÃûº£ÄÚÍⲩʿÁìÏÎÑï×Ó½­ÐÂÒ©Ñо¿ÔºµÄÊÂÇ飬£¬£¬£¬ £¬ £¬£¬ÆóÒµ½¨ÉèÁËÖÐÒ©¡¢»¯Ñ§Ò©¡¢ÉúÎïÒ©ÒÔ¼°Ò©ÎïÖÆ¼ÁÐÂÊÖÒÕ¹ú¼ÒÖØµãʵÑéÊÒµÈÑз¢Æ½Ì¨¡£¡£¡£¡£¡£½èÖú¹ú¼Ò¼¶ÆóÒµÊÖÒÕÖÐÐÄ¡¢²©Ê¿ºó¿ÆÑÐÊÂÇéÕ¾¡¢ÔºÊ¿ÊÂÇéÕ¾¡¢ÖÐÒ©ÖÆÒ©¹¤ÒÕÊÖÒÕ¹ú¼Ò¹¤³ÌÑо¿ÖÐÐĵÈÁ¢ÒìÆ½Ì¨£¬£¬£¬£¬ £¬ £¬£¬Ñï×Ó½­Ò©Òµ¿ÆÑÐЧ¹ûÒ»Ö±Ó¿ÏÖ¡£¡£¡£¡£¡£Ê®Ò»Îåʱ´ú£¬£¬£¬£¬ £¬ £¬£¬Ñï×Ó½­Ò©ÒµÒÑÀÛ¼ÆÍê³ÉÖÖÖÖÐÂÒ©Á¢Ïî65Ï£¬£¬£¬ £¬ £¬£¬ÆäÖÐÁ¢ÒìÒ©Îï26Ï£¬£¬£¬ £¬ £¬£¬ÉêÇë·¢Ã÷רÀû56Ï£¬£¬£¬ £¬ £¬£¬»ñÊÚȨ·¢Ã÷רÀû18Ï£¬£¬£¬ £¬ £¬£¬¹ú¼Ê·¢Ã÷רÀû8¼þ£¬£¬£¬£¬ £¬ £¬£¬Öƶ©¶à¸ö²úÆ·µÄÐÐÒµ±ê×¼44Ï£¬£¬£¬ £¬ £¬£¬Ñо¿Ôº×ª»¯Ð²úƷЧ¹û27Ï£¬£¬£¬ £¬ £¬£¬Ð²úÆ·ÏúÊÛÕ¼¼¯ÍÅÏúÊ۵ıÈÖØÉÏÉýµ½50%¡£¡£¡£¡£¡£Ñо¿Ôº·õ»¯µÄÃ÷ÐDzúÆ·¾­Ç°Æ½¿ÅÁ£»£»£»£»£»£»£»£»ñµÃ¹ú¼Ò¿Æ¼¼Ç°½ø¶þµÈ½±¡¢ÖлªÖÐҽҩѧ»áÒ»µÈ½±¡¢¹ú¼Ò·¢Ã÷רÀûÓÅÒì½±¡£¡£¡£¡£¡£¶À¼ÒÆ·ÖÖ°ÙÀÖÃß½ºÄÒ»ñ¹ú¼Ò·¢Ã÷רÀûÌØÊâ½ð½±¡£¡£¡£¡£¡£Ñï×Ó½­Ò©Òµ¼¯Íű»¹ú¼Ò¿Æ¼¼²¿¡¢¹ú×Êί¡¢ÖлªÌìÏÂ×ܹ¤»áÊÚÓè¹ú¼ÒÊ×Åú¡°Á¢ÒìÐÍÆóÒµ¡±¡£¡£¡£¡£¡£
http://www.cnpharma.net/?action-viewnews-itemid-2667